Дексмедетомидин Ever Valinject

Dexmedetomidine Ever Valinject is a sedative medication used in medical settings for sedation. It belongs to the class of alpha-2 adrenergic agonists and is administered intravenously. This product is manufactured by Ever Valinject GmbH and is available in the EU.

Dexmedetomidine is primarily used for sedation of mechanically ventilated patients in intensive care units. It may also be used for procedural sedation in non-intubated patients, such as during surgeries or diagnostic procedures. This medication helps patients remain calm and comfortable while receiving medical care. It is not typically used for general anesthesia or pain relief.

Dexmedetomidine produces a calming effect by acting on certain receptors in the brain. Patients may experience drowsiness and reduced anxiety while receiving this medication. It does not typically cause significant respiratory depression, making it useful in settings where breathing must be closely monitored. Some patients may feel lightheaded or experience a slow heart rate during administration.

Dexmedetomidine should only be administered by healthcare professionals in a clinical setting. Patients with certain heart conditions, low blood pressure, or advanced age may require closer monitoring. It is important to disclose all medications and medical conditions to the healthcare provider before receiving this drug. Alcohol and other sedatives should be avoided during treatment.

Dexmedetomidine may interact with other sedatives, opioids, or medications that slow the heart rate. Combining it with alcohol or certain antidepressants could increase the risk of side effects. Patients taking CYP2D6 inhibitors or other drugs affecting the central nervous system should use caution. Always inform your healthcare provider about all medications you are taking.